about
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney functionAmphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney functionFungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Paracoccidioides-host Interaction: An Overview on Recent Advances in the ParacoccidioidomycosisCandida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsThe Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous LeishmaniasisSphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance.Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.Atrioventricular block related to liposomal amphotericin B.Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans.An investigation of the inhibitory effects of dendrosomal nanocurcumin on Candida albicans and systemic candidiasis in BALB/c mice.Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drugForazoline A: marine-derived polyketide with antifungal in vivo efficacySmall-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.Valley fever: danger lurking in a dust cloudNovel low-cost thermotherapy for cutaneous leishmaniasis in PeruHigh-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitorsThe diversity and antimicrobial activity of Preussia sp. endophytes isolated from Australian dry rainforests.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.Antiparasitic activity of plumericin & isoplumericin isolated from Plumeria bicolor against Leishmania donovani.Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical auditInhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosumIn vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin BPolymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisA tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.Invasive fungal infections in acute leukemia.In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.Nylon-3 polymers with selective antifungal activityOutcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groupsA drug utilization evaluation study of amphotericin B in neutropenic patients in a teaching hospital in iran.The Hsp90 Co-chaperones Sti1, Aha1, and P23 Regulate Adaptive Responses to Antifungal Azoles.Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female.
P2860
Q24187699-20939700-F60E-49D2-A01B-FFFCB02BF8BCQ24198155-CE7B987A-2A40-4882-8B30-CBD5742F9472Q26740363-C96F58C0-F201-47E0-AF18-B6652CCAB5BFQ26774694-470CEAD5-50C8-43AB-97FB-8C5ACFC58190Q26863344-068144A2-4E95-4250-AA04-9C5EF278A440Q28551926-EB73A7CD-9BDF-4D27-AEF7-D5D5E71E8023Q33622748-27C9BFBE-CBC7-4DFE-8F70-500F2FF589C3Q33743364-9450BAC6-F637-452C-BA51-C24217CC18B7Q33744152-5B13CA3B-B815-46B4-BF74-77FB4125E05DQ33798459-D035EB21-1C2B-4A9B-8FD1-9D51EC6745CFQ33807138-EEB1F718-C35C-44E9-B384-3841549CB975Q33851306-A3134F43-7586-4734-A12E-B80B11641E02Q33947926-BD03CC26-CD5B-4C73-ACAA-17CEB55A1021Q34298854-7912760B-2BA2-4E50-A6DB-308089794FADQ34302880-8AC2B770-97AA-4796-8379-9473DF1E2300Q34431906-3E25D87E-89EF-4C5A-93DD-0A13A6E8CBE9Q34578357-C2C62934-24D8-4DCC-83EC-2B77206BB114Q34596780-17DD9F96-7F7B-4E86-8787-3EDB70F7E8A2Q34600693-0835B427-8DA1-43ED-B0E5-20BF19CF5D65Q34713385-16216A1A-9781-4FA0-AA4B-E4B920CD2947Q34729487-B65EAC48-C7E1-4D07-84FC-F09E15A3562DQ34969843-D90E8D9C-A8B8-4864-B722-CC52F960764BQ35168703-2C1683AB-11ED-4ABF-A5FE-322935B79A67Q35646926-AB089096-66CF-4CAE-8C44-6BEE350A6B5DQ35853546-729F3A22-488F-422A-8A91-7BA959496EBFQ35974693-5A094B86-138A-4743-B797-5C291391462AQ35976889-BB7D42F8-529D-4D74-8376-B5B693BCEA5EQ36018571-66778890-6EE6-4B72-A60A-FA1C8230D720Q36086462-7D6E180B-927D-4880-8A34-DAD0FB099707Q36218870-1E283A20-CF88-4586-BCA8-2FDCA472093FQ36257537-60DDAF6E-BBAF-47F5-B598-13D11404EFACQ36463811-3552AFB1-1D00-450C-87DF-B31B904D3555Q36482989-0B062AFD-6C4C-4427-B962-AFC98F8EF038Q36612597-D42A44CE-BC3D-4F12-9EF6-D021AEDAAA36Q36667135-C0E2D15A-23B3-495E-8C64-85F6985BDF28Q36933390-63A0ACE7-BD3B-4796-B66B-0209543509C4Q37260918-2BD80376-2F17-49D7-996F-C6A2C09C69BBQ37268162-3863A5D9-050F-40E9-995E-2870FE944A12Q37310037-7F15586F-05D6-47E7-B15D-F692DDB95A19Q37316465-84362DF0-D363-47BB-A46A-1DD1635C732F
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Amphotericin B: side effects and toxicity.
@ast
Amphotericin B: side effects and toxicity.
@en
type
label
Amphotericin B: side effects and toxicity.
@ast
Amphotericin B: side effects and toxicity.
@en
prefLabel
Amphotericin B: side effects and toxicity.
@ast
Amphotericin B: side effects and toxicity.
@en
P1476
Amphotericin B: side effects and toxicity.
@en
P2093
Maria Noemí Cabrales-Vargas
Rafael Laniado-Laborín
P304
P356
10.1016/J.RIAM.2009.06.003
P577
2009-12-01T00:00:00Z